Description
What is Survodutide?
Survodutide (Dual GLP-1R/GCGR agonist — BI 456906) is a Synthetic fatty acid-conjugated peptide. Dual GLP-1R and glucagon receptor co-agonist (not GIPR). Unlike tirzepatide (GLP-1R+GIPR), survodutide targets GLP-1R+GCGR — the same receptor pairing as the glucagon component of retatrutide. NASH Phase 2b: significant liver fat reduction, NASH resolution. Clinical-stage GCGR+GLP-1R compound.








Reviews
There are no reviews yet.